AI-generated analysis. Always verify with the original filing.
Minerva Neurosciences announced President Geoff Race's resignation effective March 31, 2026, with settlement terms and consultancy role, alongside appointment of James O’Connor as Chief Business Officer and General Counsel effective April 21, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | |---|---|
of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for p
. | Other Events. | |---|---| Effective April 21, 2026, James O’Connor was appointed by the Board, upon the recommendation of the Nominating and Corporate Gover
| Financial Statements and Exhibits. | |---|---| (d) Exhibits. Exhibit No.: 10.1† | Description: Settlement Agreement, dated as of March 30, 2026, by and among
Geoffrey Race
Effective: 2026-03-31
N/A
James O’Connor
Effective: 2026-04-21
N/A